Yazar "Cinar, E." seçeneğine göre listele
Listeleniyor 1 - 8 / 8
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe CHARACTERISTICS, RISK FACTORS AND OUTCOMES OF PATIENTS WITH A HISTORY OF HIP FRACTURE(Springer London Ltd, 2020) Kirazli, Y.; Baklaci, M.; Cinar, E.; Calis, F.; Tuncer, M.; Ozkayin, N.; Aktuglu, K.[No Abstract Available]Öğe DEMOGRAPHIC AND DISESASE CHARACTERISTICS OF PATIENTS WITH OSTEOPOROTIC HIP FRACTURES(Springer London Ltd, 2021) Kirazli, Y.; Baklaci, M.; Cinar, E.; Selbes, E. C.; Calis, F.; Ozkayin, N.; Aktuglu, K.[No Abstract Available]Öğe DO POSTURAL DEFORMITIES IN PATIENTS WITH ANKYLOSING SPONDYLITIS CAUSE BALANCE PROBLEMS?(Bmj Publishing Group, 2014) Cinar, E.; Akkoc, Y.; Karapolat, H.; Keser, G.Öğe The Effect of Cardiac Rehabilitation on Functional Capacity, Psychological Symptoms and Quality of Life in Patients with a Left Ventricular Assist Device(Elsevier Science Inc, 2016) Cinar, E.; Karapolat, H.; Capaci, K.; Engin, C.; Yagdi, T.; Ozbaran, M.; Nalbantgil, S.; Zoghi, M.Öğe Ki-67 scoring in neuroendocrine tumors of the pancreas: Alternative solutions(Springer, 2013) Cinar, E.; Aykutlu, U.; Basar, E.; Uguz, A.; Uluer, H.; Ipek, F. N.; Coker, A.; Yilmaz, F.Öğe Neurogenic bladder in patients with traumatic spinal cord injury: treatment and follow-up(Nature Publishing Group, 2014) Yildiz, N.; Akkoc, Y.; Erhan, B.; Gunduz, B.; Yilmaz, B.; Alaca, R.; Gok, H.; Koklu, K.; Ersoz, M.; Cinar, E.; Karapolat, H.; Catalbas, N.; Bardak, A. N.; Turna, I.; Demir, Y.; Gunes, S.; Alemdaroglu, E.; Tunc, H.Study design: Multi-center, cross-sectional study. Objectives: Our aim was to evaluate the treatment methods and follow-up of neurogenic bladder in patients with traumatic spinal cord injury retrospectively using a questionnaire. Setting: Turkey. Methods: Three hundred and thirty-seven patients who had spinal cord injury for at least 2 years were enrolled from six centers in the neurogenic bladder study group. They were asked to fill-out a questionnaire about treatments they received and techniques they used for bladder management. Results: The study included 246 male and 91 female patients with a mean age of 42 +/- 14 years. Intermittent catheterization (IC) was performed in 77.9% of the patients, 3.8% had indwelling catheters, 13.8% had normal spontaneous micturition, 2.6% performed voiding maneuvers, 1.3% used diapers and 0.6% used condom catheters. No gender difference was found regarding the techniques used in bladder rehabilitation (P > 0.05). Overall, 63.2% of patients used anticholinergic drugs; anticholinergic drug use was similar between genders (P > 0.05). The most common anticholinergic drug used was oxybutynin (40.3%), followed by trospium (32.6%), tolterodine (19.3%) darifenacin (3.3%), propiverine (3.3%) and solifenacin (1.1%). The specialties of the physicians who first prescribed the anticholinergic drug were physiatrists (76.2%), urologists (22.1%) and neurologists (1.7%). Only four patients had previously received injections of botulinum-toxin-A into the detrusor muscle and three of them stated that their symptoms showed improvement. Most of the patients (77%) had regular follow-up examinations, including urine cultures, urinary system ultrasound and urodynamic tests, when necessary; the reasons for not having regular control visits were living distant from hospital (15.3%) and monetary problems (7.7%). Of the patients, 42.7% did not experience urinary tract infections (UTI), 36.4% had bacteriuria but no UTI episodes with fever, 15.9% had 1-2 clinical UTI episodes per year and 5% had >= 3 clinical UTIs. The clinical characteristics of patients with and without UTI (at least one symptomatic UTI during 1 year) were similar (P40.05). The frequency of symptomatic UTI was similar in patients using different bladder management techniques (P > 0.05). Conclusion: The most frequently used technique for bladder rehabilitation in patients with SCI was IC (77.9%). In all, 63.2% of patients used anticholinergic drugs, oxybutynin being the most commonly used drug. Also, 77% of patients had regular control visits for neurogenic bladder; 42.7% did not experience any UTIs.Öğe Prognostic Value of Cardiopulmonary Exercise Test Parameters in Ventricular Assist Device Therapy(Elsevier Science Inc, 2021) Gallastegi, A. Dorken; Ergi, D. G.; Kahraman, U.; Yagmur, B.; Cinar, E.; Karapolat, H. Uzumcugil; Ozbaran, M.[No Abstract Available]Öğe RISK FACTORS ASSESSMENT OF PATIENTS OPERATED FOR OSTEOPOROTIC HIP FRACTURE(Springer London Ltd, 2021) Baklaci, M.; Kirazli, Y.; Cinar, E.; Aktuglu, K.; Ozkayin, N.; Tamsel, I.[No Abstract Available]
